Compare PGIM India Healthcare Fund vs ICICI Prudential Healthcare Fund
PGIM India Healthcare Fund
EquitySectoral-Pharma
ICICI Prudential Healthcare Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹1000
₹100
Expense Ratio
2.65
2.07
NAV
₹11.75
₹44.81
Fund Started
19 Nov 2024
25 Jun 2018
Fund Size
₹130.33 Cr
₹6861.20 Cr
Exit Load
Exit load of 0.50%, if redeemed within 90 days.
Exit load of 1% if redeemed within 15 days.
1 Year
13.23%
2.11%
3 Year
-
19.35%
5 Year
-
13.95%
Equity
94.89%
98.91%
Cash
-0.13%
1.09%
Top 10 Holdings
Name | Assets |
|---|---|
Divi's Laboratories Ltd. | 10.36% |
Sun Pharmaceutical Industries Ltd. | 10.25% |
Torrent Pharmaceuticals Ltd. | 8.49% |
Ajanta Pharma Ltd. | 4.96% |
Max Healthcare Institute Ltd. | 4.71% |
Dr. Lal Pathlabs Ltd. | 4.33% |
Mankind Pharma Ltd. | 4.04% |
Manipal Health Enterprises Ltd. | 3.68% |
Navin Fluorine International Ltd. | 3.24% |
Abbott India Ltd. | 3.12% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.49% |
Dr. Reddy's Laboratories Ltd. | 9.73% |
Cipla Ltd. | 5.79% |
Biocon Ltd. | 5.33% |
Mankind Pharma Ltd. | 5.04% |
Alkem Laboratories Ltd. | 4.81% |
Medplus Health Services Ltd. | 4.31% |
Cohance Lifesciences Ltd. | 4.06% |
Divi's Laboratories Ltd. | 3.78% |
Syngene International Ltd. | 3.50% |
Name
-
-
Start Date
-
-
Description
The scheme seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
19 Nov 2024
25 Jun 2018
